Study of BT-114143 injection for heavy menstrual bleeding
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This trial tests an investigational medication called BT-114143 for people with heavy menstrual bleeding (abnormal uterine bleeding). The goal is to see if it is safe and effective in reducing blood loss during periods.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 50 years old and still having periods (premenopausal).
- You have regular periods (every 21 to 35 days) and bleeding lasts 14 days or less.
- You have been diagnosed with heavy menstrual bleeding, with at least 80 mL of blood loss per period over two cycles or 160 mL in one cycle.
- You have a body mass index (BMI) between 18.5 and 28.0.
- You are not pregnant and agree to use effective birth control if you could become pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two medications, calcium dobesilate and tranexamic acid, to see which works better for reducing heavy menstrual bleeding. If you have heavy periods and are otherwise healthy, you may be able to join.
This trial tests if relugolix can reduce heavy menstrual bleeding caused by uterine fibroids. It may be an option for women who want to avoid surgery.
This trial tests a capsule called CMS-D002 for heavy periods caused by uterine fibroids. It might help reduce your bleeding if you have fibroids at least 2 cm in size, regular cycles, and are between 18 and 50.
This trial tests an experimental drug called HMI-115 to see if it reduces pain from endometriosis. If you have moderate to severe period pain and non-period pain, and you have a surgical diagnosis, you may be able to join.
This early-stage study tests medicines that may help control heavy uterine bleeding by changing how blood clots work in the uterus. If you have regular periods and meet the setup rules, you may be asked to provide menstrual tracking and undergo an endometrial (uterine lining) biopsy.
This study tests whether different types of hormonal medication (such as pills or an intrauterine device) can help manage heavy periods in adolescents and young adults. The goal is to find what works best for reducing bleeding and improving quality of life.
Hear when a new Abnormal Uterine Bleeding trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.